Prognostic factors of minimally invasive surgery for gastric cancer: Does robotic gastrectomy bring oncological benefit?

Journal: World journal of gastroenterology
Published Date: Oct 21, 2021

Abstract

BACKGROUND: Gastric cancer is the third leading cause of cancer-related death worldwide and surgical resection remains the sole curative treatment for gastric cancer. Minimally invasive gastrectomy including laparoscopic and robotic approaches has been increasingly used in a few decades. Thus far, only a few reports have investigated the oncological outcomes following minimally invasive gastrectomy.

Authors

  • Masaya Nakauchi
    Department of Gastroenterological Surgery, Fujita Health University, Toyoake 470-1192, Aichi, Japan.
  • Koichi Suda
    Division of Upper GI, Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan, ko-suda@nifty.com.
  • Susumu Shibasaki
    Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, N15, W7, Kita-Ku, Sapporo, 060-8638 Hokkaido Japan.
  • Kenichi Nakamura
    Department of Gastroenterological Surgery, Fujita Health University, Toyoake 470-1192, Aichi, Japan.
  • Shinichi Kadoya
    Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa 920-8535, Ishikawa, Japan.
  • Kenji Kikuchi
    Department of Gastroenterological Surgery, Fujita Health University, Toyoake 470-1192, Aichi, Japan.
  • Kazuki Inaba
    Department of Gastroenterological Surgery, Fujita Health University, Toyoake 470-1192, Aichi, Japan.
  • Ichiro Uyama

Keywords

External Resources

Popular Topics
Recent Journals